Hemideina has raised funds via a private placement
Hemideina has raised US$7.4 million. The capital raised will be used to fund product development in preparation for the first human studies.
Hemideina is a Melbourne-based private company that is set to disrupt the cochlear implant market through its proprietary mechanical signal processing technology, the Hera wireless implant system. The company aims to provide a paradigm shift in hearing implant performance that will lead to increased access and adoption of treatment.
Oaklins’ team in Australia acted as lead manager in this transaction. The team has assisted Hemideina with fundraising since 2018 and is proud to support them on their mission to positively impact the lives of people with severe-to-profound hearing loss.
CEO and Co-founder, Hemideina
Talk to the deal team
Managing DirectorMelbourne, Australia
Sale of Global Security Glazing and Dlubak Specialty Glass Corporation to Isoclima Group
Global Security Glazing and Dlubak Specialty Glass Corporation have been acquired by Isoclima Group, a portfolio company of Stirling Square Capital Partners.Learn more
Ro Health has received a majority investment from Achieve Partners
The owners of Ro Health, Inc., one of the fastest-growing providers of nursing and behavioral therapy solutions in school and home health environments, have sold the company to Achieve Partners.Learn more
Michel Design Works has been acquired by Stonewall Kitchen
The founder and owner of Michel Design Works Ltd. has sold the company to Stonewall Kitchen, a portfolio company of Audax Private Equity.Learn more